These steps include things like course-broad basic safety labeling alterations and new submit-advertising needs for all ER/LA opioid analgesics. FDA also responded to 2 citizen petitions regarding labeling of opioids. Within an open up letter to prescribers on March one, FDA and overall health Expert businesses asked all prescribers of opioids to